Minwoo Nam joined Samsung Biologics in 2025 and has played a key role in ADC analytical method development. He has over 10 years of experience in the pharmaceutical industry. Prior to joining the company, he led several small-molecule projects at SK pharmteco, where he was responsible for analytical method development and method validation. He holds a master’s degree in pharmaceutical analysis from Sungkyunkwan University.